# Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1

> **NCT06714253** · PHASE1,PHASE2 · RECRUITING · sponsor: **RiboX Therapeutics Ltd.** · enrollment: 42 (estimated)

## Conditions studied

- Radiation-Induced Xerostomia and Hyposalivation

## Interventions

- **BIOLOGICAL:** RXRG001
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT06714253
- **Lead sponsor:** RiboX Therapeutics Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-05
- **Primary completion:** 2027-08
- **Final completion:** 2027-08
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06714253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06714253, "Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06714253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*